Authors:
WEST MS
HERD JA
BALLANTYNE CM
POWNALL HJ
SIMPSON S
GOULD KL
GOTTO AM
Citation: Ms. West et al., THE LIPOPROTEIN AND CORONARY ATHEROSCLEROSIS STUDY (LCAS) - DESIGN, METHODS, AND BASE-LINE DATA OF A TRIAL OF FLUVASTATIN IN PATIENTS WITHOUT SEVERE HYPERCHOLESTEROLEMIA, Controlled clinical trials, 17(6), 1996, pp. 550-583
Citation: K. Yoshida et al., CORONARY FLOW AND FLOW RESERVE BY PET SIMPLIFIED FOR CLINICAL-APPLICATIONS USING RB-82 OR NITROGEN-13-AMMONIA, The Journal of nuclear medicine, 37(10), 1996, pp. 1701-1712
Citation: Kl. Gould, VERY LOW-FAT DIETS FOR CORONARY HEART-DISEASE - PERHAPS, BUT WHICH ONE - REPLY, JAMA, the journal of the American Medical Association, 275(18), 1996, pp. 1402-1403
Citation: Kl. Gould, CHANGES IN MYOCARDIAL PERFUSION ABNORMALITIES BY POSITRON EMISSION TOMOGRAPHY AFTER LONG-TERM, INTENSE RISK FACTOR MODIFICATION (VOL 274, PG 894, 1995), JAMA, the journal of the American Medical Association, 275(15), 1996, pp. 1160-1160
Citation: Ld. Berry et Kl. Gould, NOVEL ALLELES OF CDC13 AND CDC2 ISOLATED AS SUPPRESSORS OF MITOTIC CATASTROPHE IN SCHIZOSACCHAROMYCES-POMBE, MGG. Molecular & general genetics, 251(6), 1996, pp. 635-646
Authors:
HERD JA
BALLANTYNE CM
FARMER JA
FERGUSON JJ
GOULD KL
JONES PH
WEST MS
GOTTO AM
Citation: Ja. Herd et al., THE EFFECT OF FLUVASTATIN ON CORONARY ATHEROSCLEROSIS - THE LIPOPROTEIN AND CORONARY ATHEROSCLEROSIS STUDY (LCAS), Circulation, 94(8), 1996, pp. 3496-3496
Citation: Gj. Denhaese et al., THE WEE1 PROTEIN-KINASE REGULATES T14 PHOSPHORYLATION OF FISSION YEAST CDC2, Molecular biology of the cell, 6(4), 1995, pp. 371-385
Authors:
SMITH SC
BLAIR SN
CRIQUI MH
FLETCHER GF
FUSTER V
GERSH BJ
GOTTO AM
GOULD KL
GREENLAND P
GRUNDY SM
HILL MN
HLATKY MA
HOUSTONMILLER N
KRAUSS RM
LAROSA J
OCKENE IS
OPARIL S
PEARSON TA
RAPAPORT E
STARKE RD
Citation: Sc. Smith et al., PREVENTING HEART-ATTACK AND DEATH IN PATIENTS WITH CORONARY-DISEASE, Journal of the American College of Cardiology, 26(1), 1995, pp. 292-294
Authors:
GOULD KL
ORNISH D
SCHERWITZ L
BROWN S
EDENS RP
HESS MJ
MULLANI N
BOLOMEY L
DOBBS F
ARMSTRONG WT
MERRITT T
PORTS T
SPARLER S
BILLINGS J
Citation: Kl. Gould et al., CHANGES IN MYOCARDIAL PERFUSION ABNORMALITIES BY POSITRON EMISSION TOMOGRAPHY AFTER LONG-TERM, INTENSE RISK FACTOR MODIFICATION, JAMA, the journal of the American Medical Association, 274(11), 1995, pp. 894-901
Authors:
MCCOLLUM D
BALASUBRAMANIAN MK
PELCHER LE
HEMMINGSEN SM
GOULD KL
Citation: D. Mccollum et al., SCHIZOSACCHAROMYCES-POMBE CDC4(-HAND PROTEIN ESSENTIAL FOR CYTOKINESIS() GENE ENCODES A NOVEL EF), The Journal of cell biology, 130(3), 1995, pp. 651-660
Authors:
SMITH SC
BLAIR SN
CRIQUI MH
FLETCHER GF
FUSTER V
GERSH BJ
GOTTO AM
GOULD KL
GREENLAND P
GRUNDY SM
HILL MN
HLATKY MA
HOUSTONMILLER N
KRAUSS RM
LAROSA J
OCKENE IS
OPARIL S
PEARSON TA
RAPAPORT E
STARKE RD
Citation: Sc. Smith et al., PREVENTING HEART-ATTACK AND DEATH IN PATIENTS WITH CORONARY-DISEASE, Circulation, 92(1), 1995, pp. 2-4
Authors:
OHI R
MCCOLLUM D
HIRANI B
DENHAESE GJ
ZHANG X
BURKE JD
TURNER K
GOULD KL
Citation: R. Ohi et al., THE SCHIZOSACCHAROMYCES-POMBE CDC5(-MYB() GENE ENCODES AN ESSENTIAL PROTEIN WITH HOMOLOGY TO C), EMBO journal, 13(2), 1994, pp. 471-483
Citation: Kl. Gould, INVASIVE PROCEDURES IN ACUTE MYOCARDIAL-INFARCTION - ARE THEY BENEFICIAL, JAMA, the journal of the American Medical Association, 272(11), 1994, pp. 891-893
Citation: Jd. Burke et Kl. Gould, MOLECULAR-CLONING AND CHARACTERIZATION OF THE SCHIZOSACCHAROMYCES-POMBE HIS3 GENE FOR USE AS A SELECTABLE MARKER, MGG. Molecular & general genetics, 242(2), 1994, pp. 169-176
Citation: Mk. Balasubramanian et al., THE SCHIZOSACCHAROMYCES-POMBE CDC3+ GENE ENCODES A PROFILIN ESSENTIALFOR CYTOKINESIS, The Journal of cell biology, 125(6), 1994, pp. 1289-1301
Citation: Kl. Gould, REVERSAL OF CORONARY ATHEROSCLEROSIS - CLINICAL PROMISE AS THE BASIS FOR NONINVASIVE MANAGEMENT OF CORONARY-ARTERY DISEASE, Circulation, 90(3), 1994, pp. 1558-1571
Authors:
GOULD KL
MARTUCCI JP
GOLDBERG DI
HESS MJ
EDENS RP
LATIFI R
DUDRICK SJ
Citation: Kl. Gould et al., SHORT-TERM CHOLESTEROL-LOWERING DECREASES SIZE AND SEVERITY OF PERFUSION ABNORMALITIES BY POSITRON EMISSION TOMOGRAPHY AFTER DIPYRIDAMOLE IN PATIENTS WITH CORONARY-ARTERY DISEASE - A POTENTIAL NONINVASIVE MARKER OF HEALING CORONARY ENDOTHELIUM, Circulation, 89(4), 1994, pp. 1530-1538
Citation: K. Yoshida et Kl. Gould, QUANTITATIVE RELATION OF MYOCARDIAL INFARCT SIZE AND MYOCARDIAL VIABILITY BY POSITRON EMISSION TOMOGRAPHY TO LEFT-VENTRICULAR EJECTION FRACTION AND 3-YEAR MORTALITY WITH AND WITHOUT REVASCULARIZATION, Journal of the American College of Cardiology, 22(4), 1993, pp. 984-997
Authors:
ORNISH D
BROWN SE
BILLINGS JH
ARMSTRONG WT
PORTS TA
MERRITT T
SPARLER S
SPANN L
MCLANAHAN S
SCHERWITZ LW
KIRKEEIDE RL
BRAND RJ
GOULD KL
Citation: D. Ornish et al., CAN LIFE-STYLE CHANGES REVERSE CORONARY ATHEROSCLEROSIS - 4-YEAR RESULTS OF THE LIFE-STYLE HEART TRIAL, Circulation, 88(4), 1993, pp. 385-385
Citation: Kl. Gould, QUANTITATIVE-ANALYSIS OF CORONARY-ARTERY RESTENOSIS AFTER CORONARY ANGIOPLASTY - HAS THE ROSE LOST ITS BLOOM, Journal of the American College of Cardiology, 19(5), 1992, pp. 946-947
Authors:
GOULD KL
ORNISH D
KIRKEEIDE R
BROWN S
STUART Y
BUCHI M
BILLINGS J
ARMSTRONG W
PORTS T
SCHERWITZ L
Citation: Kl. Gould et al., IMPROVED STENOSIS GEOMETRY BY QUANTITATIVE CORONARY ARTERIOGRAPHY AFTER VIGOROUS RISK FACTOR MODIFICATION, The American journal of cardiology, 69(9), 1992, pp. 845-853